SCHEMBL28082142

SCHEMBL28082142

COc1ccc(NC(=O)Nc2ccc(NS(C)(=O)=O)cc2)cc1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 5/20 0.73
NPC1 O15118 4/20 0.73
SMN1; SMN2 Q16637 4/20 0.73
CA1 P00915 2/20 0.65
CA2 P00918 2/20 0.65
CA12 O43570 1/20 0.65
CA9 Q16790 1/20 0.65
LMNA P02545 1/20 0.64
GAA P10253 1/20 0.64
MAPK1 P28482 1/20 0.64
MAPT P10636 4/20 0.61
MEN1 O00255 2/20 0.61
KMT2A Q03164 2/20 0.61
KDM4E B2RXH2 2/20 0.61
SAE1 Q9UBE0 1/20 0.61
UBA2 Q9UBT2 1/20 0.61
TP53 P04637 2/20 0.59
ESR2 Q92731 1/20 0.59
NOX1 Q9Y5S8 1/20 0.59
TSHR P16473 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL171658 0.88 LMNA (0.79) RAB9ANPC1SMN1; SMN2CA1CA2
SCHEMBL11092496 0.86 RAB9A (1.00) RAB9ANPC1SMN1; SMN2CA1CA2
SCHEMBL28082173 0.85 TSHR (0.74) RAB9ANPC1SMN1; SMN2LMNAGAA
SCHEMBL3468171 0.83 LMNA (0.64) RAB9ANPC1SMN1; SMN2CA1CA2
SCHEMBL18500598 0.83 MAPT (0.61) RAB9ANPC1SMN1; SMN2CA1CA2
SCHEMBL3116450 0.82 PGR (0.73) RAB9ANPC1SMN1; SMN2CA1CA2
SCHEMBL4668688 0.82 LMNA (0.72) RAB9ANPC1SMN1; SMN2CA1CA2
SCHEMBL17628550 0.80 RAB9A (0.88) RAB9ANPC1SMN1; SMN2CA1CA2
SCHEMBL12010894 0.80 PGR (0.68) RAB9ANPC1SMN1; SMN2LMNAGAA
SCHEMBL12010877 0.79 PGR (0.70) RAB9ANPC1SMN1; SMN2LMNAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103570723-B Pyrazolopyrimidine derivative and preparation method thereof and the purposes in prepared by medicine 广西梧州制药(集团)股份有限公司 2016-07-13 CN disclosed